# MRI for Tumor During Chemoradiation for Anal Canal and Perianal Cancer

> **NCT01053923** · — · WITHDRAWN · sponsor: **University Health Network, Toronto**

## Conditions studied

- Anal Cancer Patients
- Perianal Patients

## Interventions

- **OTHER:** Magnetic Resonance Imaging (MRI)

## Key facts

- **NCT ID:** NCT01053923
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Patient eligibility has limited accrual and patient sample has changed with the change in referral patients.
- **Last updated:** 2013-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053923, "MRI for Tumor During Chemoradiation for Anal Canal and Perianal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01053923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*